Background and Purpose: This meta-analysis quantified mean effects of moderate-to-vigorous intensity locomotor training (LTmv) on walking outcomes in subacute and chronic stroke, and the magnitude of individual variability in LTmv response. Methods: Databases were searched for randomized trials comparing LTmv with no intervention, non-gait intervention or low-intensity gait training. Comfortable gait speed (CGS), fastest gait speed (FGS), 6-minute walk distance (6MWT), walking activity (steps/day) and adverse effect/event (AE) data were extracted. Pooled estimates were calculated for mean changes within and between groups, the relative risk of different AEs, and the standard deviation of individual response (SDIR) to LTmv versus control groups, stratified by study chronicity where possible. Results: There were 19 eligible studies (total N=1,096); 14 in chronic stroke (N=839) and 5 in subacute stroke (N=257). Compared with control interventions, LTmv yielded significantly greater increases in CGS, FGS and 6MWT in both subacute and chronic stroke, with subacute studies showing significantly greater effect sizes for CGS, FGS and nearly 6MWT (p=0.054). In 4 studies reporting steps/day data, LTmv was not significantly different from control interventions. In 14 studies reporting on AEs, there were no treatment-related serious AEs among 398 LTmv participants. SDIR estimates indicated significant individual response variability for CGS, nearly FGS (p=0.0501) and 6MWT. Discussion and Conclusions: LTmv improves mean walking capacity outcomes in subacute and chronic stroke and does not appear to have high risk of serious harm, but response magnitude varies between chronicity subgroups and individuals, and few studies have tested effects on daily walking activity or non-serious AEs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.